L-2-Hydroxyglutarate Biosensor Using LhgR-FRET Signal Conversion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting intracellular L-2-hydroxyglutarate (L-2-HG) are time-consuming and lack spatial and temporal resolution, hindering real-time monitoring and diagnostic techniques.

Innovation Solution

Development of an L-2-hydroxyglutarate biosensor based on a specific transcriptional regulator, LhgR, coupled with Forster Resonance Energy Transfer (FRET) technology, which utilizes a fusion protein of cyan fluorescent protein mTFP and yellow fluorescent protein Venus to detect L-2-HG concentration through conformational changes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional methods (LC-MS/MS, GC-MS/MS) are used to detect L-2-HG, then measurement precision is achieved, but detection speed and productivity deteriorate due to time-consuming procedures

Engineering Contradiction:
ImproveL-2-HG detection accuracyVSAvoiddetection speed
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent replaces complex mechanical/chemical separation systems (LC-MS/MS, GC-MS/MS) with a biological sensing system based on FRET. The biosensor uses fluorescent protein conformational changes upon L-2-HG binding to directly generate optical signals, eliminating the need for chromatographic separation and mass spectrometry analysis, thus achieving rapid detection without sacrificing precision

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces a transcriptional regulator as an intermediary element that specifically binds to L-2-HG and triggers conformational changes in the fluorescent protein. This intermediary translates the chemical binding event into an optical signal, enabling direct fluorescence-based detection that is both rapid and precise

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If conventional methods are used, then comprehensive metabolic analysis is possible, but spatial and temporal resolution deteriorate, preventing real-time monitoring

Engineering Contradiction:
Improvemetabolic analysis capabilityVSAvoidreal-time monitoring capability
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces batch processing analytical methods with a real-time optical sensing system. The FRET-based biosensor continuously monitors L-2-HG levels through fluorescence intensity changes, providing temporal resolution that enables dynamic metabolic analysis rather than static snapshots

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent utilizes fluorescence intensity changes (optical property changes) as the biosensor responds to L-2-HG binding. The conformational changes in the fluorescent protein alter emission properties, providing real-time visualizable data on metabolic dynamics

Inventive Principle:
Principle #32Color changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The biosensor enables rapid, sensitive, and accurate detection of L-2-HG concentrations in various biological samples and real-time monitoring of intracellular dynamics, providing results consistent with conventional methods like LC-MS/MS.

Implementation Method 1

coupled with Forster Resonance Energy Transfer (FRET) technology, which utilizes a fusion protein of cyan fluorescent protein mTFP and yellow fluorescent protein Venus to detect L-2-HG concentration through conformational changes

Methodology Applied
Scientific EffectForster Resonance Energy Transfer (FRET):

Implementation Method 2

a fusion protein of cyan fluorescent protein mTFP and yellow fluorescent protein Venus to detect L-2-HG concentration through conformational changes

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12429423B2L-2-hydroxyglutarate biosensor based on specific transcriptional regulator and application thereof
Publication Date: 2025.09.30 SHANDONG UNIV
  • US12429423B2 patent drawing
  • US12429423B2 patent drawing
  • US12429423B2 patent drawing

AI summary

A transcriptional regulator LhgR is specifically responsive to L-2-hydroxyglutarate (L-2-HG) and an L-2-HG biosensor based on this transcriptional regulator; wherein the biosensor is a fusion protein of cyan fluorescent protein mTFP, L-2-HG specific transcriptional regulator LhgR, and yellow fluorescent protein Venus, including three types of L-2-HG biosensor LHGFR0N0C, LHGFR0N3C, and LHGFR0N7C. The application of the L-2-HG biosensor in the detection of L-2-HG-containing biological samples, real-time detection of intracellular L-2-HG concentration in bacteria and in human cells. The experiments confirmed that the biosensor can achieve high specificity, sensitivity, and accuracy in the detection of L-2-HG and can determine intracellular L-2-HG dynamics in real time, which has good application prospects.